Intravenous solutions market is expected to register a considerable growth by 2031
Posted by Sanyukta K on September 9th, 2022
The intravenous solutions market is projected to show the fastest growth in the home care settings segment during the forecast period, owing to the rise in the geriatric population.
The overall parenteral nutrition segment is expected to grow with the largest share during the forecast period. This is attributed to intravenous solutions market trends such as increased use of total parenteral nutrition. On the other hand, the partial parenteral nutrition segment is projected to exhibit the fastest market growth during the forecast period due to new product launches and increase in demand for its products.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/17466
Hospitals and clinics segment was the major revenue contributor in 2021 and this trend is expected to continue during the forecast period due to increase in number of hospitals and clinics and metabolic problems.
The factors that drive growth of the global intravenous solutions market include increase in the prevalence of malnutrition, the faster response time and higher efficacy associated with intravenous solution therapy and surge in the geriatric population. However, lack of experienced healthcare professionals and complications of intravenous administration therapy are expected to hinder the market growth. Conversely, the high growth opportunities in emerging markets are expected to offer lucrative opportunities for growth of market
Intravenous solutions restore fluid to the intravascular compartment, and some intravascular fluids are also used to facilitate the movement of fluid between compartments by osmosis. These fluids can be isotonic, hypertonic and hypotonic. Isotonic solutions are fluids that have the same concentration of dissolved particles as blood.
Additionally, adoption of unhealthy lifestyles, growing elderly population and increasing government initiatives also contributed to the growth of the market. By composition, the single dose amino acid segment was the major revenue contributor in 2021 and is expected to continue this trend during the forecast period due to the increase in the number of cancer patients.
Like it? Share it!
About the AuthorSanyukta K
Joined: July 13th, 2022
Articles Posted: 49
More by this author